Zhong Yi, Guo Wei, Wang Li, Chen Xinming
Department of Oral and Maxillofacial Surgery, Nineth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai Key Laboratory of Stomatology, Shanghai, Peoples Republic of China.
Ann Maxillofac Surg. 2011 Jul;1(2):145-9. doi: 10.4103/2231-0746.92780.
The aim of the present article was to review the current new knowledge on the molecular markers of tumor invasion in ameloblastoma. In this review, tumor molecular markers were identified and allocated to the following six groups according to their functions: (I) Markers involved in extracellular matrix degradation, (II) Molecular markers involved in cell adhesion lost, (III) Molecular markers involved in bone remodeling, (IV) Cytokines involved in angiogenesis, (V) Molecular markers related with the function of tumor stromal cells on the invasion of ameloblastoma, and (VI) Molecular markers involved in cell proliferation related with invasion. In general, the location of markers within the tumor and not their quantitative assessments as such is emphasized. Data showed that the correlation among molecular markers of invasive relevance is still not quite clear. Results on markers of tumor invasion and metastatic potential appeared to be too premature for a statement regarding the instinct invasive nature of ameloblastoma. The unraveling of specific new details concerning these mechanisms, whereby the expression and relationships among the molecules are mediated, may provide an opportunity to afford efficient prevention and develop new treatment therapies.
本文的目的是综述成釉细胞瘤中肿瘤侵袭分子标志物的当前新知识。在本综述中,肿瘤分子标志物根据其功能被识别并分为以下六组:(I)参与细胞外基质降解的标志物,(II)参与细胞黏附丧失的分子标志物,(III)参与骨重塑的分子标志物,(IV)参与血管生成的细胞因子,(V)与肿瘤基质细胞对成釉细胞瘤侵袭功能相关的分子标志物,以及(VI)与侵袭相关的细胞增殖相关分子标志物。一般来说,强调的是标志物在肿瘤内的位置而非其定量评估。数据表明,具有侵袭相关性的分子标志物之间的相关性仍不太清楚。关于肿瘤侵袭和转移潜能标志物的结果对于就成釉细胞瘤的固有侵袭性作出陈述而言似乎还为时过早。阐明有关这些机制的具体新细节,即分子之间的表达和关系是如何介导的,可能会提供一个进行有效预防和开发新治疗方法的机会。